Artelo Biosciences (Artelo Biosciences) Additional Paid-In Capital : $52.53 Mil(As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Artelo Biosciences Additional Paid-In Capital?

Artelo Biosciences's quarterly additional paid-in capital increased from Sep. 2023 ($52.01 Mil) to Dec. 2023 ($52.26 Mil) and increased from Dec. 2023 ($52.26 Mil) to Mar. 2024 ($52.53 Mil).

Artelo Biosciences's annual additional paid-in capital increased from Aug. 2021 ($28.93 Mil) to Dec. 2022 ($50.68 Mil) and increased from Dec. 2022 ($50.68 Mil) to Dec. 2023 ($52.26 Mil).

Artelo Biosciences Additional Paid-In Capital Historical Data

The historical data trend for Artelo Biosciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artelo Biosciences Additional Paid-In Capital Chart

Artelo Biosciences Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

10.28

13.27

28.93

50.68

52.26

Artelo Biosciences Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															51.03	51.25	52.01	52.26	52.53

Artelo Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Artelo Biosciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Artelo Biosciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Artelo Biosciences (Artelo Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artelo Biosciences Inc (NAS:ARTLW) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

ARTL:USA

Address

505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075

Website

https://www.artelobio.com

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing and commercializing treatments that control endocannabinoid system. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.